てんかんは再発性の発作を特徴とする神経疾患であり、この疾患の治療には多くの薬剤が利用可能です。薬剤の選択は、てんかんのタイプ、患者の年齢、患者の全身状態や他の疾患の有無などの他の要因によって異なります。しかし、てんかん患者数の増加により、てんかん治療薬市場は拡大しています。神経疾患のひとつであるてんかんは、世界的な有病率の上昇により、市場を牽引する大きな要因となっています。さらに、人口の増加、高齢化、診断の向上などの要因により、てんかんに罹患する人が増加しており、これらすべてが市場の拡大に寄与しています。例えば、UpToDate Inc.社が2021年8月に発表したレポートによると、てんかん罹患率は年齢とともに上昇し、75歳以上で最も高くなっています。その結果、高齢者人口のてんかん有病率の上昇がてんかん治療薬の需要を牽引し、市場の成長を支えています。
さらに、政府当局による新薬承認の増加は、予測期間中に市場に有利な需要を創出すると予測されている。例えば、2022年3月、米国食品医薬品局はルピン（Lupin）社のビガバトリン承認のための短縮新薬申請（ANDA）を認めました。これは抗てんかん薬で、
また、2022年3月、米国食品医薬品局は、遺伝性てんかんであるCDKL5欠損症の人々の発作を治療するために、マリナス・ファーマシューティカルズ（Marinus Pharmaceuticals）社の薬剤Ztalmyを承認しました。その結果、医薬品承認の増加は、予測期間中の市場の成長をサポートすると予想されます。さらに、てんかん薬に関連する研究開発活動の増加により、予測期間中に市場に有利な機会が生まれると予想されます。ただし、薬に関連する副作用は、2023年から2030年の予測期間を通じて市場の成長を阻害するでしょう。
世界のてんかん治療薬市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、主要な市場プレイヤーの存在、てんかんの負担増、同地域の市場プレイヤーによる戦略的イニシアティブ、啓発キャンペーン、新製品の開発などにより、2022年の市場を支配した。アジア太平洋地域は、高齢者人口の増加、てんかん有病率の増加、インドや中国の新興経済国における高いアンメット・メディカル・ニーズの存在などの要因により、予測期間中に大きく成長すると予想される。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epilepsy Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Epilepsy Drugs Market, by Drugs, 2020-2030 (USD Billion)
1.2.3. Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Epilepsy Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Epilepsy Drugs Market Dynamics
3.1. Epilepsy Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the New Drug Approvals over the Past Few Years
3.1.1.2. Growing Prevalence of Epilepsy
3.1.2. Market Challenges
3.1.2.1. Side Effects Associated with the Drugs
3.1.3. Market Opportunities
3.1.3.1. Rising Research and Development Activities Related to Epilepsy Drugs
Chapter 4. Global Epilepsy Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Epilepsy Drugs Market, by Drugs
5.1. Market Snapshot
5.2. Global Epilepsy Drugs Market by Drugs, Performance - Potential Analysis
5.3. Global Epilepsy Drugs Market Estimates & Forecasts by Drugs 2020-2030 (USD Billion)
5.4. Epilepsy Drugs Market, Sub Segment Analysis
5.4.1. First Generation Anti-epileptics
5.4.2. Second Generation Anti-epileptics
5.4.3. Third Generation Anti-epileptics
Chapter 6. Global Epilepsy Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Epilepsy Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Epilepsy Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Epilepsy Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacy
6.4.2. Pharmacy Stores
6.4.3. Others
Chapter 7. Global Epilepsy Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Epilepsy Drugs Market, Regional Market Snapshot
7.4. North America Epilepsy Drugs Market
7.4.1. U.S. Epilepsy Drugs Market
7.4.1.1. Drugs breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Epilepsy Drugs Market
7.5. Europe Epilepsy Drugs Market Snapshot
7.5.1. U.K. Epilepsy Drugs Market
7.5.2. Germany Epilepsy Drugs Market
7.5.3. France Epilepsy Drugs Market
7.5.4. Spain Epilepsy Drugs Market
7.5.5. Italy Epilepsy Drugs Market
7.5.6. Rest of Europe Epilepsy Drugs Market
7.6. Asia-Pacific Epilepsy Drugs Market Snapshot
7.6.1. China Epilepsy Drugs Market
7.6.2. India Epilepsy Drugs Market
7.6.3. Japan Epilepsy Drugs Market
7.6.4. Australia Epilepsy Drugs Market
7.6.5. South Korea Epilepsy Drugs Market
7.6.6. Rest of Asia Pacific Epilepsy Drugs Market
7.7. Latin America Epilepsy Drugs Market Snapshot
7.7.1. Brazil Epilepsy Drugs Market
7.7.2. Mexico Epilepsy Drugs Market
7.8. Middle East & Africa Epilepsy Drugs Market
7.8.1. Saudi Arabia Epilepsy Drugs Market
7.8.2. South Africa Epilepsy Drugs Market
7.8.3. Rest of Middle East & Africa Epilepsy Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. GlaxoSmithKline plc
8.3.3. Sanofi S.Aa
8.3.4. UCB S.A.
8.3.5. Abbott Laboratories
8.3.6. Bausch Health Companies, Inc
8.3.7. Viatris Inc.
8.3.8. Johnson & Johnson
8.3.9. Sumitomo Pharma Co., Ltd
8.3.10. H. Lundbeck A/S.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
List of Tables
TABLE 1. Global Epilepsy Drugs Market, report scope
TABLE 2. Global Epilepsy Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Epilepsy Drugs Market estimates & forecasts by Drugs 2020-2030 (USD Billion)
TABLE 4. Global Epilepsy Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Epilepsy Drugs Market
TABLE 70. List of primary sources, used in the study of global Epilepsy Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Epilepsy Drugs Market, research methodology
FIG 2. Global Epilepsy Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Epilepsy Drugs Market, key trends 2022
FIG 5. Global Epilepsy Drugs Market, growth prospects 2023-2030
FIG 6. Global Epilepsy Drugs Market, porters 5 force model
FIG 7. Global Epilepsy Drugs Market, pest analysis
FIG 8. Global Epilepsy Drugs Market, value chain analysis
FIG 9. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Epilepsy Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Epilepsy Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
